Osaic Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66K | Buy |
1,980
+1,352
| +215% | +$45.1K | ﹤0.01% | 4490 |
|
|
2025
Q1 | $20.6K | Sell |
628
-494
| -44% | -$16.2K | ﹤0.01% | 5317 |
|
|
2024
Q4 | $40.6K | Sell |
1,122
-7
| -0.6% | -$253 | ﹤0.01% | 4826 |
|
|
2024
Q3 | $35.2K | Buy |
1,129
+42
| +4% | +$1.31K | ﹤0.01% | 4972 |
|
|
2024
Q2 | $29.1K | Sell |
1,087
-2,188
| -67% | -$58.5K | ﹤0.01% | 5042 |
|
|
2024
Q1 | $112K | Sell |
3,275
-6,335
| -66% | -$216K | ﹤0.01% | 4165 |
|
|
2023
Q4 | $278K | Sell |
9,610
-3,208
| -25% | -$92.8K | ﹤0.01% | 3660 |
|
|
2023
Q3 | $353K | Buy |
12,818
+4,496
| +54% | +$124K | ﹤0.01% | 3542 |
|
|
2023
Q2 | $250K | Buy |
8,322
+71
| +0.9% | +$2.13K | ﹤0.01% | 3722 |
|
|
2023
Q1 | $299K | Sell |
8,251
-94
| -1% | -$3.41K | ﹤0.01% | 3559 |
|
|
2022
Q4 | $298K | Sell |
8,345
-15,495
| -65% | -$553K | ﹤0.01% | 3519 |
|
|
2022
Q3 | $806K | Buy |
23,840
+19,413
| +439% | +$656K | ﹤0.01% | 2432 |
|
|
2022
Q2 | $127K | Buy |
4,427
+169
| +4% | +$4.85K | ﹤0.01% | 4207 |
|
|
2022
Q1 | $138K | Sell |
4,258
-131
| -3% | -$4.25K | ﹤0.01% | 4329 |
|
|
2021
Q4 | $128K | Buy |
4,389
+370
| +9% | +$10.8K | ﹤0.01% | 4360 |
|
|
2021
Q3 | $107K | Sell |
4,019
-145
| -3% | -$3.86K | ﹤0.01% | 4466 |
|
|
2021
Q2 | $129K | Buy |
4,164
+169
| +4% | +$5.24K | ﹤0.01% | 4256 |
|
|
2021
Q1 | $104K | Buy |
3,995
+2,514
| +170% | +$65.4K | ﹤0.01% | 4300 |
|
|
2020
Q4 | $38K | Sell |
1,481
-2,680
| -64% | -$68.8K | ﹤0.01% | 4733 |
|
|
2020
Q3 | $87K | Buy |
4,161
+124
| +3% | +$2.59K | ﹤0.01% | 3921 |
|
|
2020
Q2 | $95K | Buy |
4,037
+529
| +15% | +$12.4K | ﹤0.01% | 3714 |
|
|
2020
Q1 | $63K | Buy |
+3,508
| New | +$63K | ﹤0.01% | 3795 |
|